Laboratory Services
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spike Antibody, Semi-Quantitative, Serum
Print this pageUpdated Test Information:
Test Description |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Spike Antibody, Semi-Quantitative, Serum
|
|
---|---|---|
Synonym(s) |
Coronavirus, Coronavirus Ab, Coronavirus antibody, COVID-19 Ab, COVID-19, COVID-19 antibody, SARS CoV-2 Ab, SARS CoV-2, SARS CoV-2 antibody |
|
Test ID |
COVSQ
|
|
General Information |
Aiding in the identification of individuals with an adaptive immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), indicating prior infection or vaccination Manufacture of coronavirus disease 2019 (COVID-19) convalescent plasma This test provides semi-quantitative detection of serum antibodies against the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). This test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection and/or vaccination. |
|
Container Type |
SST or Red top |
|
Specimen Type |
Serum |
|
Specimen Requirements |
Preferred: Serum gel |
|
Specimen Collection / Processing Instructions |
SST - Separate serum or plasma from cells within 45 minutes of collection. Red top: Centrifuge and remove serum from red blood cells within 2 hours of draw. Aliquot serum to submission container (plastic vial). |
|
Minimum Sample Volume |
0.75mL |
|
Stability |
Refrigerated (preferred): 7 days |
|
Unacceptable Specimen Conditions |
Improper labeling, quantity not sufficient, improper collection container, gross hemolysis |
|
Methodology |
Electrochemiluminescence Immunoassay (ECLIA) |
|
Estimated TAT |
1-3 days |
|
Testing Schedule |
Monday - Saturday |
|
Test Includes |
SARS-CoV-2 Spike Ab, Semi-Quant, S |
|
CPT Code(s) |
86769 |
|
Reference Range |
Negative |
|
Performing Lab |
Mayo Clinic |
|
LOINC Code(s) |
94769-7 |